ALB and cancer: There have been several previously published reviews focusing on the application of albumin-based nanocarriers in drug delivery from different aspects, including preparation methods, surface modification, albumin cellular receptors, albumin-based drug delivery strategies, cancer multimode therapy, drug delivery routes, and market-approved products (Elzoghby et al., 2012; Larsen et al., 2016; Tan and Ho, 2018; Karami et al., 2020; Li et al., 2020).